Daily Stock List
Rackwise, Inc. (RACK)
Greenbackers reported recently on Rackwise, Inc. (RACK), PennyTrader Publisher did earlier, and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Listed on the OTCQB, Rackwise, Inc. is a leader in software development and marketing within the growing data center infrastructure management (DCIM) market for IT infrastructure tracking, monitoring, modeling, and management. More than 150 companies globally use Rackwise® products and services. The Company’s flagship product is Rackwise DCiM X™. Rackwise has their headquarters in Folsom, California.
Rackwise delivers IT infrastructure data center analytics and intelligence that enable Executive and Data Center Management to track and optimize asset utilization; monitor and adjust power and energy usage for cost savings; control overall and LOB Information Technology (IT) costs; plan for future growth and/or consolidation with impact analysis; measure progress towards achieving Green data center initiatives, and ensure business continuity.
Their Rackwise DCiM X™ incorporates open architecture designs into a vendor agnostic platform. This affords IT professionals' maximum flexibility for efficient integration in any computing environment. The Rackwise DCiM X™ offering provides features and functionalities to assure reliability, identify hidden capacity, and improve efficiencies resulting in accelerated returns on investments via significantly optimized data center facilities and IT infrastructures.
DCiM X™ integrates device level, real-time monitoring with advanced modeling, reporting, analytics, and other critical capabilities. These enable clients to more effectively manage today's high density computing configurations and virtualized data centers, mitigate risks associated with cascading faults and other potential inefficiencies within the infrastructure, and facilitate progress to more sustainable "green" data centers.
Yesterday, Rackwise announced that they executed a license agreement with Lincoln Electric System (LES) to install and deploy Rackwise DCiM X™ in LES's multiple data centers in the Lincoln, Nebraska area. LES, a regional electric energy provider, is a nonprofit, customer-owned utility serving more than 200 square miles within Lancaster County, including Lincoln and other major cities. LES's main goal is to provide a reliable electric supply at the lowest possible cost to their more than 113,000 residential customers and 15,000 commercial and industrial customers.
Rackwise, Inc. (RACK), closed today’s session at $0.166, up 3.75%, on 334,200 volume with 34 trades. The average volume for the last 60 days is 40,044 and the stock's 52-week low/high is $0.138/$1.79
Houston American Energy Corp. (HUSA)
TheStockfather, OTCPicks, Jason Bond, Ultimate Penny Stock, Wall Street Resources, The Street, Stock Analyzer, StreetInsider, and Greenbackers reported earlier on Houston American Energy Corp. (HUSA), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.
Houston American Energy Corp. is an independent energy company with interests in oil and natural gas wells and prospects. Their business strategy includes a property mix of producing and non-producing assets with a focus on Colombia, Texas, and Louisiana. Houston American Energy typically looks to form partnerships and joint ventures to spread the cost and risks to the Company of drilling while maximizing their potential returns. Incorporated in April 2001, the Company has their corporate headquarters in Houston, Texas.
Houston American Energy's principal producing and exploration properties in Louisiana include East Baton Rouge Parish. They hold a 37.55 percent Working Interest (WI) in the Profit Island and North Profit Island prospects, covering 4,670 gross acres in East Baton Rouge Parish, Louisiana. They also hold a 7.29 percent royalty interest in 2,485 royalty acres, and a 5.675 percent royalty interest in the Crown Paper #01 well.
Properties in Louisiana also include Plaquemines Parish. They hold a 1.80 percent WI in the SL 180771 well and prospect; this covers 300 gross acres. They also have their Vermilion Parish property. They hold a 2.25 percent WI in the 830 acre La Furs, Inc. F-16 well and prospect.
Their principal exploration properties in Texas include Jim Hogg County. They hold a 4.375 percent WI in the 340 acre Hog Heaven Prospect in Jim Hogg County, Texas. The Company also has their Matagorda Country property. They hold a 3.50 percent WI in the 779 acre Harrison Prospect in Matagorda County, Texas.
In the Llanos Basin, Colombia, Houston American Energy holds interests in a 345,452 acre concession known as the CPO 4 concession, the La Cuerva concession covering approximately 48,000 acres, and the LLA 62 concession covering approximately 40,000 acres. In the Northern Putumayo Basin, they hold interest in one concession and two technical evaluation agreements.
Last week, the Company announced that drilling operations on the Zorro Gris #1 well were continuing with drilling operations proceeding at approximately 7,400 feet as of September 25, 2012. The Zorro Gris well was spud on September 1, 2012; it has a target depth of approximately 13,094 feet. Results of the Zorro Gris #1 well, their third well on their CPO 4 block in Colombia, will be announced when available.
Yesterday, Houston American Energy announced that they closed on their previously announced registered direct equity offering of 14,814,815 units at $0.675 per unit, with each unit consisting of one of the Company's common shares, one Class A Warrant to purchase one-half share of common stock, and one Class B Warrant to purchase one half share of common stock. This is for gross proceeds of approximately $10.0 million, before deducting placement agent fees and offering expenses. The Company intends to use the proceeds from the offering for general working capital purposes. This includes funding their share of costs of development of properties in which the Company holds interests.
Houston American Energy Corp. (HUSA), closed today’s session at $0.58, up 5.19%, on 1,127,369 volume with 3,082 trades. The average volume for the last 60 days is 423,799 and the stock's 52-week low/high is $0.58/$17.05.
American Bonanza Gold Corp. (BZA.TO)
Vantage Wire reported previously on American Bonanza Gold Corp. (BZA.TO), and today we highlight the Company, here at the QualityStocks Daily Newsletter.
Headquartered in Vancouver, British Columbia, American Bonanza Gold Corp. is operating the Copperstone gold mine in Arizona. The Copperstone property contains a 10.3 g/t oxide gold resource with 313,000 ounces of gold in the Measured and Indicated categories and 256,000 ounces of gold in the Proven and Probable Mineral Reserves category. The Company continues to optimize other assets to benefit the development of Copperstone, where permitting is complete. American Bonanza Gold's shares trade on the Toronto Stock Exchange.
The potential to expand the gold deposits at Copperstone near the underground mine workings is excellent. The mineral reserves are open to depth where the potential is undrilled. The second area of potential is near the south end of the planned mine workings. This second area is quantified as an Inferred Resource.
In mid-September, American Bonanza Gold announced progress and second quarter results from operations at the newly constructed high-grade Copperstone gold mine in Arizona. They continue to work towards their objective of achieving commercial production this fall. Commercial production is planned at 450 tons per day of ore mined and the production of 46,000 ounces of gold per year during the first three years of the mine life.
During this past summer, Copperstone made progress towards bringing development mining forward. The initial backfilling cycle (in the D Zone) was completed; development mining has now reached a second main mining zone (the C Zone), and is nearing a third (Lower D Zone).
In September, American Bonanza Gold also announced arrangements of additional funding. The Company completed a non-brokered private placement (the Offering) to continue ramping up production at the Copperstone gold mine and for general working capital. They issued 25,000,000 units at a price of $0.20 per Unit for gross proceeds of $5,000,000. The Company also reported the expansion of the Gold Loan Facility. A third party, arms-length investor invested an additional US$1.5 million via Bonanza's existing Gold Loan (News Release dated June 14, 2012), increasing the size of the facility to US$6 million.
American Bonanza Gold Corp. (BZA.TO), closed today’s session at $0.205, down 2.38%, on 235,400 volume. The stock's 52-week low/high is $0.19/$0.65.
Voice Assist, Inc. (VSST)
OTCPicks, Bull in Advantage, and Buzz Stocks reported earlier on Voice Assist, Inc. (VSST), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.
Headquartered in Lake Forest, California, Voice Assist, Inc. is an award-winning provider of mobile speech solutions. The design of these is to be used from any phone. These solutions eliminate the requirement to press buttons on smartphones, tablet PCs, or other network-connected devices. Additionally, the Company offers their hands-free safe driving application and CRM-by-voice applications direct to the public and/or through resellers and private label original equipment manufacturers (OEM) relationships. Voice Assist shares trade on the OTCBB.
Voice Assist merges the latest speech technology with internet-based information and a premier telecommunications network. Voice Assist (with a speech driven user interface) is well suited for a mobile hands busy environment. Voice Assist is a fast and safe way to make calls, manage e-mails, and send text messages by voice commands over the phone. It is the network based virtual assistant platform that is engine agnostic and works on every handset, PC, tablet, and IPTV or Internet Radio.
A user calls a Voice Assist access number and says what they want to do. Mobile developers and cloud-based service providers can take advantage of Voice Assist's platform to provide voice access to any application by way of their rapid application development environment and mobile widgets. This makes it easy to add a powerful voice interface to almost any application. The Voice Assist platform takes advantage of SpeechScript™ - the Company’s patent pending rapid application development environment. SpeechScript™ enables developers to build once and apply applications to many devices, fast.
In June, Voice Assist announced the launch of their Live Assist™ personal concierge service. Live Assist is available 24/7 to provide answers and assistance to mobile subscribers, from any phone, anywhere. Live Assist is helpful while on the go, providing a wealth of valuable information. Live Assist works on 100 percent of all mobile phones and connects mobile subscribers to their own live personal concierge for fast, accurate, and convenient assistance. Live Assist is a cloud-based service that does not require a download to one's phone.
In September, Voice Assist announced that they released their new application for the Android operating system. Voice Assist for Android provides a safe driving application that lets drivers use voice commands to call, email, text, as well as post to social networks such as Twitter and Facebook - no typing is required. The user interface was optimized for productive safe driving with the ability to issue repeated commands without the need to hold the phone or press buttons repeatedly.
Voice Assist, Inc. (VSST), closed today’s session at $0.12, down 7.69%, on 15,375 volume with 5 trades. The average volume for the last 60 days is 49,872 and the stock's 52-week low/high is $0.06/$0.81
Donner Metals Ltd. (DON.V)
We are highlighting Donner Metals Ltd. (DON.V) today, here at the QualityStocks Daily Newsletter.
Headquartered in Vancouver, British Columbia, Donner Metals Ltd. is an exploration and development company that lists on the TSX Venture Exchange. The Company focuses on the zinc-copper Matagami Project, a joint venture project with Xstrata Canada Corp. - Xstrata Zinc Canada. Development of the Bracemac-McLeod deposit is currently well underway, with production scheduled to begin in Quarter 1 2013.
Donner's flagship project in the Matagami Mining Camp covers both the current development of a new mine, as well as on-going exploration activities. The project is in the Abitibi region of central Quebec and it is supported by Xstrata's existing mine infrastructure, a highly experienced workforce and an operating 2,950 tonne per day mill. In addition, the area is serviced by highway, power, airport, and railway and town site infrastructure.
The Matagami Project has an area of mutual interest of 4,737 square kilometers that is governed by the Matagami Joint Venture Agreement signed in 2006 between Donner Metals and Falconbridge Ltd., now Xstrata Canada. The project is centered on the town of Matagami. The area of mutual interest is divided into 6 separate joint venture (JV) areas that cover claims in which Donner holds an interest with Xstrata. Under the JV agreement, Xstrata Canada - Xstrata Zinc Canada Division is the project operator for the Matagami Project and its relative JV's.
The Bracemac-McLeod deposit is 6 kilometers from Xstrata's Matagami mill complex. Mineral concentrates produced in Matagami are processed and refined at Xstrata's facilities in Rouyn - Noranda and Montreal, Quebec. In addition to the construction of the Bracemac-McLeod mine, a second deposit called PD1 is currently under feasibility study. Donner Metals also holds property interests in the Voisey's Bay area in Labrador and an ownership interest in Knight Resources Ltd. The Company's focus is on the exploration for zinc, copper, as well as nickel deposits.
Last month, Mr. Harvey Keats, Chief Executive Officer of Donner Metals reported on exploration results for drilling conducted in the vicinity of the Bracemac-McLeod Deposit and within the 4,737 square kilometer Matagami Project as reported to the Company by partner and project operator Xstrata Canada Corporation-Xstrata Zinc Canada Division. Renewed exploration diamond drilling up-dip from the McLeod Zone discovered new copper mineralization within a laterally extensive chlorite alteration zone. This includes 2.83 percent copper over 19.35 meters intersected in hole MCL-12-16, drilled 45 meters up-dip from earlier drilling on the McLeod Zone. Exploration drilling also intersected 13.09 g/t silver and 0.13 g/t gold over 19.35 meters. Two drills are currently active on the project.
Donner Metals Ltd. (DON.V), closed today’s session at $0.19, up 2.70%, on 49,533 volume. The stock's 52-week low/high is $0.16/$0.27.
High Desert Gold Corp. (HDG.V)
We are reporting on High Desert Gold Corp. (HDG.V), here at the QualityStocks Daily Newsletter.
Listed on the TSX Venture Exchange, High Desert Gold Corp. is a mineral exploration company that acquires and explores mineral properties, primarily gold, copper, and silver in North America. The main property that they hold is the 60 percent Gold Springs gold project along the border between Utah and Nevada. There has been insufficient exploration to define a property-wide mineral resource at Gold Springs. It is uncertain if more exploration will result in the additional targets at Gold Springs being delineated as a mineral resource. High Desert Gold has their corporate headquarters in Vancouver, British Columbia, and an exploration office in Denver, Colorado.
The Company also holds direct interests in a number of other properties. These include the San Antonio project in Sonora, Mexico, the Gold Lake property in New Mexico, the Artillery Peak property in Arizona, and the Kinkaid, Pinyon, and Snow properties in Nevada. They also have a 34.2 percent interest in the Canasta Dorada property in Sonora, Mexico, via their equity interest in Highvista Gold, Inc.
The focus of the Company's exploration program this year is the Gold Springs project. They planned a 6,400-meter drill program. In addition, High Desert Gold is conducting extensive surface geological, geochemical, and geophysical exploration. Their intention is to update the existing resource by the end of 2012.
Yesterday, High Desert Gold announced that the Company has now completed 34 holes in the first phase drill program at Gold Springs; they will begin the second phase, which is expected to include 10 to 15 holes, today, October 5, 2012. This phase of the exploration program will also include trenching in the area of the high-grade intercept at Grey Eagle, where GE 12-002 intersected 62.5 meters of 2.39 g/t goldEq (62.5m @ 2.1 g/t gold and 16.4 g/t silver). The design of this program is to expand the previously reported Jumbo resource and potentially develop an initial resource on the Grey Eagle target.
In addition, High Desert Gold announced the results from the last four holes of the first phase drill program at Gold Springs, two from the Jumbo Zone and two from the Shark's Belly target, both located in Utah. The two drill holes in the Jumbo area showed good continuity with the higher-grade mineralization seen in nearby holes. The two drill holes at the Shark's Belly intersected low-grade, geochemically anomalous gold mineralization.
High Desert Gold Corp. (HDG.V), closed today’s session at $0.25, up 13.95%, on 1,199,540 volume. The stock's 52-week low/high is $0.11/$0.35.
Panoramic Resources Ltd. (PANRF)
We are highlighting Panoramic Resources Ltd. (PANRF), here at the QualityStocks Daily Newsletter.
Panoramic Resources Ltd. engages in the exploration, evaluation, development, and production of mineral deposits. The Company has a significant exploration portfolio in Australia and overseas, primarily focusing on nickel, copper, and gold. Panoramic Resources has their headquarters in Perth, Australia. The Company's shares trade on the Pink Sheets (OTC Pink Current Information).
Panoramic employs more than 500 people. The Company’s vision is now to broaden their exploration and production base. Their corporate goal is to become a major, diversified mining house in the S&P/ASX Top 100. Panoramic is broadly engaged in exploration activities in Australia, Canada, the U.S., and Scandinavia.
Panoramic Resources owns and operates in Western Australia the Savannah (East Kimberley) and Lanfranchi (Kambalda) underground nickel mines. Additionally, the Company recently acquired the Gidgee Gold Project (Murchison). Furthermore, Panoramic is also the operator of the Copernicus Project (60 percent) - a satellite open pit nickel mine near Savannah that is currently on care and maintenance.
The Company's Savannah Project is 240 kilometers south of Kununurra in the East Kimberley region of Western Australia. It consists of a nickel sulphide ore body, an underground mine, a process plant, and associated infrastructure.
Their Lanfranchi Operations and associated Tramways Tenements (the Lanfranchi Project) are 42 kilometers south of Kambalda, Western Australia. Panoramic Resources acquired a 75 percent interest in the Lanfranchi Project from BHP Billiton Nickel West in June 2004. In 2009, they purchased the remaining 25 percent from their Joint Venture partner, Brilliant Mining Corp.
The Company's Gidgee Gold Project is approximately 640 kilometers northeast of Perth. This project includes a 600,000 tonnes per year process facility, a 150-person camp, as well as a large, highly prospective tenement package already containing 310,000 ounces of gold in Resource. Panoramic's initial strategy for Gidgee is to build up a resource and reserve profile and develop a mine plan that will support the re-commissioning of the existing Gidgee processing plant.
Panoramic Resources Ltd. (PANRF), closed today’s session at $0.63, up 16.67%, on 314 volume with 1 trade. The average volume for the last 60 days is 3,563 and the stock's 52-week low/high is $0.44/$1.48.
Talon International, Inc. (TALN)
HyperSpeedStocks and OTCWizard reported recently on Talon International, Inc. (TALN), Wallstreetlivechat did earlier, and we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Founded in 1980, Talon International, Inc. is a worldwide supplier of apparel fasteners, trim, and interlining products. The Company supplies these products to manufacturers of fashion apparel, specialty retailers, brand licensees, mass merchandisers, as well as major retailers. Talon International has offices and facilities in the U.S. (headquarters in Los Angeles), the UK, Hong Kong, China, Taiwan, India, and Bangladesh. The Company lists on the OTCQB.
Talon manufactures and distributes zippers and other fasteners under their Talon® brand. This brand has a reputation as the original American zipper invented in 1893. The Company also designs, manufactures, engineers, and distributes apparel trim products and specialty waistbands under their trademark names, Talon, Tag-It, and TekFit. These are to major apparel brands and manufacturers including Wal-Mart, Kohl's, J.C. Penney, Victoria's Secret, Tom Tailor, Abercrombie and Fitch, Polo Ralph Lauren, Fat Face, Phillips-Van Heusen, Reebok, and Juicy Couture.
Talon International has sold the Tekfit© technology under such brands as Polo Ralph Lauren, Roundtree & Yorke, Jack Nicklaus and Bobby Jones Golf, Eddie Bauer and Levi's Dockers. Previously more than 50 million Tekfit© waistbands were used by Levi Strauss in their Dockers pants. Today, Tekfit© waistbands are being incorporated into quality sports and casual apparel by major retailers such as Dillard's, HMX and Saks 5th Avenue.
In September, Talon International announced an end to their extended legal battle with Pro-Fit Holdings, Ltd. regarding Talon's rights to the patented Tekfit© stretch-waistband technology, and that the Company has now completed the process of securing those patent rights within the U.S. as well as the ability to market this technology around the world. Their TekFit division delivers cutting-edge product innovation to the apparel industry. TekFit has exclusive rights to advanced fabric technologies, which facilitate the addition of mechanical stretch into most standard fabrics.
This past Monday, Talon International announced the appointment of Mr. Herman Roup as V.P. of Operations - Tekfit© Division. Mr. Roup is to direct Talon's efforts to remind retailers regarding the advantages of the advanced, patented stretch-waistband technology available with their Tekfit© products.
Talon International, Inc. (TALN), closed today’s session at $0.03, even with yesterday's close, on 10,000 volume with 2 trades. The average volume for the last 60 days is 15,201 and the stock's 52-week low/high is $0.025/$0.13.
International Stem Cell Corp. (ISCO)
The QualityStocks Daily Newsletter would like to spotlight International Stem Cell Corp. (ISCO). Today, International Stem Cell Corp. closed trading at $0.265, up 10.42%, on 138,700 volume with 30 trades. The stock’s average daily volume over the past 60 days is 102,562, and its 52-week low/high is $0.21/$0.835.
International Stem Cell Corp. (ISCO) specializes in the therapeutic applications of human parthenogenetic stem cells (hpSCs) and the development and commercialization of cell-based research and cosmetic products. The company was first to perfect the natural phenomenon of parthenogenesis, which utilizes unfertilized human eggs to create hpSCs. These stem cells, created in a particular form called HLA homozygous, can be immune-matched to millions of people regardless of sex or racial background, with minimal expectation of immune rejection after transplantation.
hpSCs are as pluripotent as embryonic stem cells (ESCs) and have significant therapeutic potential but their creation does not involve the destruction of a viable human embryo – thus sidestepping the controversy and ethical dilemmas associated with the use of human embryonic stem cells. Different from induced pluripotent stem cells (iPSs), hpSCs do not involve manipulation of gene expression back to a less differentiated stage – a practice that may become a safety or regulatory obstacle in clinical applications.
A relatively small number of hpSC lines can offer the potential of producing the first true stem cell bank, UniStemCell, which ISCO intends to create as a means of serving populations across the globe. The company's scientists are currently focused on using hpSC to treat severe diseases of the eye, nervous system, and liver, for which cell therapy has been clinically proven but is limited due to the unavailability of safe human cells.
In addition to its therapeutic focus, ISCO also provides two revenue streams. Firstly through its subsidiary Lifeline Cell Technology, specialized cells and growth media for biological research around the world, and secondly its subsidiary Lifeline Skin Care, the company manufactures and sells anti-aging skincare products utilizing an extract from the hpSC and by leveraging the latest discoveries in the fields of stem cell biology, nanotechnology, and skin cream formulation technology. Disclaimer
International Stem Cell Corp. Company Blog
International Stem Cell Corp. News:
International Stem Cell Corp to Participate in Upcoming Investor Conference
International Stem Cell Corp Granted Key Patent for Liver Disease Program
International Stem Cell Corp. Among SeeThruEquity Company Lineup for Fall 2012 Smallcap and Microcap Investor Conference
MusclePharm Corp. (MSLP)
The QualityStocks Daily Newsletter would like to spotlight MusclePharm Corp. (MSLP). Today, MusclePharm Corp. closed trading at $0.0055, up 3.77%, on 11,324,769 volume with 73 trades. The stock’s average daily volume over the past 60 days is 5,208,829, and its 52-week low/high is $0.0053/$0.0375.
MusclePharm Corp. (MSLP) is focused on providing a full line of Informed Choice-approved nutritional supplements that not use any substances banned in the sports industry. Now sold in more than 120 countries and available in over 10,000 U.S. retail outlets, the company's products address all categories of an active lifestyle, including muscle building, weight loss, and maintaining general fitness through a daily nutritional supplement regimen.
Current CEO Brad Pyatt founded the company to develop a superior line of nutritional supplements that would help fellow athletes improve their performance in a way that existing supplements did not. Even as the company has grown, its mission has remained the same: to improve its customers' lives, increase their ability to excel, use cutting-edge science to develop the best nutritional supplements on the market, and provide a safe option for athletes.
MusclePharm's products were developed through exhaustive research at the MusclePharm Sports Science Center Research Institute. New products are created through a six-stage research protocol that involves the expertise of top nutritional scientists. Before launching a product, the company conducts field testing using a pool of over one hundred elite professional athletes from various professional sports leagues, including the National Football League, Mixed Martial Arts, and Major League Baseball.
Over the last few years, the consumption of sports nutrition products has shifted to mainstream consumers who have become the key drivers of growth within the industry. Teenagers and college students, women, and even older individuals are now using these products to help them live a more active and healthier lifestyle. With a full line of supplements and an extensive distribution network, MusclePharm is well positioned to capitalize on the growing demand. Disclaimer
MusclePharm Corp. Company Blog
MusclePharm Corp. News:
MusclePharm Wins Three Prestigious Bodybuilding.com Awards, Including Brand of the Year, Upon Fitness Enthusiasts' Votes
MusclePharm Adds Dick's Sporting Goods To Its Growing Retail Distribution
United States Sports Academy Researchers Present Clinical Trial Results For MusclePharms' Assault™ Pre-Workout
TNI BioTech, Inc. (TNIB)
The QualityStocks Daily Newsletter would like to spotlight TNI BioTech, Inc. (TNIB). Today, TNI BioTech, Inc. closed trading at $2.35, up 10.33%, on 92,115 volume with 85 trades. The stock’s average daily volume over the past 60 days is 27,915, and its 52-week low/high is $0.72/$10.01.
TNI BioTech, Inc. (TNIB) is focused on utilizing patented immunotherapy to activate and mobilize the body's immune system to combat fatal diseases. The company's products and technologies improve the treatment and diagnosis of cancer, infections such as HIV/AIDS, and autoimmune diseases. Future initiatives include treatment for multiple sclerosis, herpes viral infections, and other conditions that result in altered-immune response.
The company's product portfolio currently includes IRT-101, an active immunotherapy that works by activating a patient's immune system against infectious diseases and tumor cells; IRT-102, an adaptive immunotherapy that works by isolating and enriching a patient's own immune cells; and IRT-103, an active immunotherapy that works by activating a patient's immune system against HIV/AIDS and tumor cells.
Leveraging the advantages of today's cutting-edge treatment options, the company aims to meet the growing demand for quality healthcare with safer, more effective radiation therapy; new-targeted drug therapies; and minimally invasive surgical alternatives around the world. TNI BioTech most recently signed a letter of intent to open clinics in Africa that will provide advanced treatment for cancer, HIV/AIDS, and autoimmune diseases.
The company plans to continue clinical trials in China during 2012 and 2013, and anticipates starting trials in the United States by early 2013.The company is also in negotiations to acquire a number of other immunotherapy products, patents, and therapies. Led by a management team with decades of experience and solid business plan, TNI BioTech is poised to improve healthcare with active and adaptive forms of improved immunotherapies. Disclaimer
TNI BioTech, Inc. Company Blog
TNI BioTech, Inc. News:
TNI BioTech Signs Agreement With Government of Malawi to Open an Oncology & Infectious Disease Clinic at Queen Elizabeth Central Hospital
TNI BioTech, Inc. Signs Memorandum of Agreement to Open Pharmaceutical Plant for the Production of IRT-103 (LDN)
Dr. Ronald Herberman Joins TNI BioTech Inc. as Senior Vice President of Research and Development and Chief Medical Officer
Loans4Less.com, Inc. (LFLS)
The QualityStocks Daily Newsletter would like to spotlight Loans4Less.com, Inc. (LFLS). Today, Loans4Less.com, Inc. closed trading at $0.033, even for the day. The stock’s average daily volume over the past 60 days is 23,077, and its 52-week low/high is $0.01/$0.51.
Loans4Less.com, Inc. (LFLS) is an online mortgage broker which matches qualified individuals seeking mortgage loans with suitable lenders who offer the company a competitive wholesale lending program. Maintaining an A+ TrustLink rating with the Better Business Bureau, the company provides competitive rates, terms, costs, daily updates, extensive market information, and trusted first-class service to the public.
Leveraging its portfolio of 62 different web domains, Loans4Less.com is focused on developing a national consumer platform for conforming residential mortgage programs and implementation of other consumer loan programs via operating providers. The company's expansion strategy includes rapidly growing revenues through strategic and cost-effective advertising, licensing, and/or third party agreements that build national recognition of the Loans4Less® brand.
The management team has accumulated many years of experience in the real estate and financial services sectors. This combination of expertise provides the knowledge and foresight necessary to get the best results for the company and their thousands of loyal clients. The team skillfully navigated through the credit crisis that destroyed much of their competition, putting the company in a stronger position to increase market share.
Loans4Less.com is not exposed to the risks and/or problems that are associated with sub-prime lending. Having never defaulting on an obligation or been involved in any litigation, the company is poised for rapid growth in today's low interest rate environment with its industry leading reputation and well established relationships with respected lenders. Disclaimer
Loans4Less.com, Inc. Company Blog
Loans4Less.com, Inc. News:
Loans4Less.com, Inc. New Audio Interview With Chairman and CEO Steven M. Hershman
Loans4Less.com, Inc. Announces Engagement of QualityStocks Investor Relations Services.
International Stem Cell Corp. is a California biotechnology company that has developed a stem cell technology based on parthenogenesis, the creation of pluripotent human stem cells from unfertilized oocytes (eggs). Parthenogenetic stem cells have a number of advantages over stem cells derived through other means.
First, parthenogenetically derived stem cells do not involve the destruction of human embryos, thus avoiding the ethical issues associated with embryonically sourced stem cells. Second, because the oocytes are unfertilized, parthenogenetic stem cells have a duplicate set of human leukocyte antigen (HLA) genes. This greatly reduces the possibility of the derived cells being rejected by an individual’s immune system, meaning that a single cell line can be suitable for the treatment of millions of individuals, and even a small number of cell lines could provide “immune matched” cells to a significant percentage of the world’s population. Third, parthenogenetic stem cells are pluripotent, able to differentiate into all sorts of specialized body cells. In summary, parthenogenetic stem cells represent a combination of advantages not shared by stem cells from other sources.
ISCO is focused on three therapeutic markets, with revenue potential of over $4.2 billion. The company is already working on applying parthenogenetic stem cells to diseases of the eye, liver, and brain, in addition to making them available to others for research. The company has developed a broad intellectual property portfolio, with freedom to operate and strong patent protection. For example, there are more than 1 million sufferers in the $2.2B market for Parkinson’s disease, currently being researched by ISCO, and there is no pluripotent stem cell based competition.
The company also has commercial operations, in the form of Lifeline Cell Technology, a business to business research products company that manufactures and markets high-quality human primary cells, media, and reagents; and Lifeline Skin Care, a company that develops, manufactures, and markets anti-aging skin care products based on growth factors and peptides extracted from human parthenogenetic stem cells.
For additional information on ISCO, visit the company’s website at www.InternationalStemCell.com
GlobalWise Investments, through its wholly owned subsidiary Intellinetics, is a leading-edge technology company focused on Enterprise Content Management (ECM) solutions for small-sized to mid-sized businesses. Their advanced cloud-based systems allow client companies to access virtually any type of company document, 24/7, from anyplace in the world, greatly leveraging the company’s intellectual base. Leading hardware vendors such as Lexmark, Samsung, DELL, and many others, already recognize the future of ECM are now directly integrating into the Intellinetics Intellivue™ cloud platform. The company’s highly knowledgeable and experienced management team has driven growth through a dramatic expansion of sales distribution.
• William J. “BJ” Santiago (President & CEO) has more than 20 years of senior executive-level management experience with an emphasis in sales, operations, and M&A activities in the public and private sectors. During his previous tenure at Lexmark, BJ was hand-selected in 2008 by the CEO to launch and lead all operations for the newly formed Content Management Sales Practices for North America, using the Intellinetics platform. Through this business venture, Intellinetics recognized his ability as an ECM industry thought leader.
• Matthew Chretien (EVP & Chief Technology Officer) is a co-founder of Intellinetics and a strategic entrepreneur backed by more than 20 years of experience in technology sales, consulting, and software product life cycle management within the aerospace, public safety, government, and commercial markets.
• Kendall “Ken” Gill (Chief Financial Officer) brings over 40 years of experience in the fields of public accounting and finance, in addition to business development and various entrepreneurial endeavors, with prior roles including serving as Audit Manager at Coopers and Lybrand.
• Michael Chretien (VP & Corporate Counsel) is co-founder of Intellinetics and brings extensive security and leadership experience for consulting and assisting with document storage and critical IT and security related solutions.
• Thomas Moss (Chief Software Engineer) is also a co-founder of Intellinetics and director of the company’s software research and development efforts, and boasts 20 years of expertise in database application design and document imaging software technologies.
• Michael Beck (Director of Operations) brings 17 years of IT experience, including IT and related project management, and technical development and design.
• Neil Campbell (Director of Software Products Group) has 16 years of IT experience, with an emphasis in infrastructure design, software architecture, and productivity improvement solutions.
• Jim Perry (Director of Business Development) has over 15 years of executive sales and marketing experience providing ECM solutions to the healthcare, government, and insurance markets.
• Bob Peterson (Director of Business Development) has over 20 years of senior management experience with an emphasis in channel sales, business development, and marketing.
To learn more about GlobalWise and its software solutions, visit www.GlobalWiseInvestments.com
Escalon Medical, founded in 1987, announced the sale of its Clinical Diagnostics Business (ECD) to ERBA Diagnostics. As part of the $6.5M cash sale, ERBA will acquire ECD, the business components of Drew Scientific, Inc., and its wholly owned subsidiaries JAS Diagnostics, Inc. (“JAS”) and Drew Scientific Limited Co. ECD develops and sells A1c and Hematology diagnostic instruments, reagents, and chemistries; Drew focuses on providing instrumentation and consumables for the physician office labs, small hospital labs, and veterinary research laboratories; and JAS specializes in the manufacture of a broad range of liquid stable, diagnostics chemistry reagents used in IVD tests.
“The sale of Escalon Clinical Diagnostics business was based on the continuing extensive strategic evaluation and enables us to better focus our efforts and resources on our Ophthalmic business” stated Richard J. DePiano, Jr., President of Escalon. “We expect to use the cash we receive in the transaction to strengthen our balance sheet, to provide additional working capital, enhance our ability to strategically expand our Ophthalmic business and provide the means to selectively pursue opportunities for synergistic growth.”
Since Escalon’s entry into the clinical diagnostics business, the strategic objective had been to expand their presence in the reagent segment of the IVD market. Drew, acquired in 2004, focused on the equipment side of the IVD business; and JAS synergistically expanded the company’s position into the clinical chemistry consumable market. Escalon restructured the business in an effort to position it for profitability. Management realized that further investment and focus was needed to move ECD into profitability and as the opportunity to seek strategic partners developed into opportunities for combinations, management pursued the opportunity presented by ERBA Diagnostics.
Escalon Clinical Diagnostics revenues from operations were $12,985,000 (2012), $13,708,000 (2011), and $18,077,000 (2010). The sale of this business will have a material effect on earnings in subsequent periods. Since 1997, the company has acquired selective business’s or product lines with a mission to enhance or expand such for the sole purpose of creating shareholder value. During this time Escalon acquired six separate businesses or product lines and has divested of five. Each divesture provided Escalon with a stronger balance sheet and provided additional working capital.
Escalon develops markets and distributes ophthalmic diagnostic and surgical products. They seek to utilize strategic partnerships to help finance its development programs and is also seeking acquisitions to further diversify its product line to achieve critical mass in sales and take better advantage of distribution capabilities. The company has headquarters in Wayne, Pennsylvania, and operations in Long Island, New York, New Berlin, Wisconsin, and Stoneham, Massachusetts.
ERBA Diagnostics develops, manufactures, and markets proprietary diagnostic reagents, instrumentation, and software, specializing in a full range of products from ERBA international group of companies in USA, Italy, Czech Republic, India, and Turkey, including not only the Autoimmune and Infectious Elisa product lines, but also the full line of biochemistry, clinical chemistry, and urine analysis products.
BIO-key International, a global leader in biometric and advanced mobile identification solutions, told investors that it will be a presenting company at the American Association of Blood Banks – Annual Meeting and CTTXPO, at the Boston Convention Center, October 6th – 9th, 2012 (Booth # 1221). The event brings together blood donor industry members to learn about the latest advances in blood banking, transfusion medicine, and cellular therapies, as well as to explore state-of-the-art products and services.
Eric Schulties, CIO at the Institute for Transfusion Medicine and winner of the CIO of the Year 2012 award in Pittsburgh, Pennsylvania, will be directing and Michele Tysarczyk, RN, BA, Executive Director, Blood Operations at Central Blood Bank, has been given the responsibility of moderating a discussion for Nurses, Managers/Supervisors, and CEOs/CFOs. The panel of speakers will include Anne Lassinger, BS, MT (ASCP); Mary Plut, MT (ASCP), CQE (ASQ); Eric Schulties, MBA, MHA; Roxanne Tata, MT(ASCP)SBB, CQA (ASQ).
This forum will begin with brief presentation of how one organization moved from a first-stage electronic donor record to a more advanced system that includes biometrics for donor and staff identification. Panelists will discuss the integration of third-party medical devices, in addition to the overall impact these projects had on key performance indicators, such as duplicate donors and documentation errors. Topics to be covered include: why biometrics and integration with medical devices were selected as strategic projects, how these projects were set up and positioned for success, and finally the group will share the key technology, process and organization decisions that were made.
Headquartered in Wall, New Jersey, BIO-key International develops and delivers advanced identification solutions to commercial and government enterprises, integrators, and custom application developers. The company’s award winning, high performance, scalable, cost-effective, and easy-to-deploy biometric finger identification technology accurately identifies and authenticates users of wireless and enterprise applications.
To learn more about the company, visit www.bio-key.com
Today's Top 3
Investor News Source
The QualityStocks Public Company Sponsor News